| Clinical Trial of YY1201 for Treatment of Osteoarthritis of the Knee (NCT02554552) | Yooyoung Pharmaceutical Co., Ltd. | 2015-09-01 |
| Phase I Study to Determine the Optimal Human Challenge Dose for a Norovirus GII.4 Challenge Stock (CIN-1) (NCT02337842) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-09-01 |
| MSC and Kidney Transplant Tolerance (Phase A) (NCT02565459) | Monia Lorini | 2015-09-01 |
| Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery (NCT02334007) | McMaster University | 2015-09-01 |
| Temporary Autonomic Blockade to Prevent Atrial Fibrillation After Cardiac Surgery (NCT02498769) | Joseph Mathew, M.D. | 2015-09-01 |
| A Pilot Study of Azithromycin Prophylaxis for Acute Chest Syndrome in Sickle Cell Disease (NCT02630394) | University of Mississippi Medical Center | 2015-09-01 |
| Safety and Immunogenicity of HBAI20 Hepatitis B Vaccine in Naive Adults and Non-responders (NCT02540538) | Maastricht University Medical Center | 2015-09-01 |
| A Study of LY3023414 in Japanese Participants With Advanced Cancer (NCT02536586) | Eli Lilly and Company | 2015-09-01 |
| Multiple Dose Study of D1971a in Healthy Volunteers (NCT02564861) | Daiichi Sankyo | 2015-09-01 |
| A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered DAA-I in Healthy Subjects (NCT02666196) | National University Hospital, Singapore | 2015-09-01 |
| Pharmacokinetic Interaction Between Diltiazem and ACT-541468 in Healthy Subjects (NCT02526888) | Idorsia Pharmaceuticals Ltd. | 2015-09-01 |
| Drug Interaction Study of MGL-3196 With Rosuvastatin and Simvastatin (NCT02542969) | Madrigal Pharmaceuticals, Inc. | 2015-09-01 |
| A Bioequivalence Study to Compare the Pharmacokinetics of Two Betrixaban Formulations (NCT02596100) | Portola Pharmaceuticals | 2015-09-01 |
| Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods (NCT02456584) | FHI 360 | 2015-09-01 |
| A Study of (Interleukin-12) IL-12 in Patients With Acute Myelogenous Leukemia (AML) (NCT02483312) | University Health Network, Toronto | 2015-09-01 |
| A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad26.RSV.FA2 Followed by Ad35.RSV.FA2 in Healthy Adult Volunteers (NCT02561871) | Crucell Holland BV | 2015-09-01 |
| Drug Interaction Study of GBT440 With Caffeine, S-warfarin, Omeprazole, and Midazolam in Healthy Subjects (NCT02567682) | Global Blood Therapeutics | 2015-09-01 |
| Pharmacokinetics and Safety of the Co-administration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Healthy Chinese Subjects (NCT02534870) | AbbVie | 2015-09-01 |
| Nutraceutical Supplement in the Management of Hypertension (NCT02663479) | Thorne HealthTech, Inc | 2015-09-01 |
| Safety, Tolerability, and Pharmacokinetics of a Single Oral Dose of SKI-O-703 in Healthy Volunteers (NCT02717988) | Oscotec Inc. | 2015-09-01 |
| Study of Granisetron Hydrochloride Nasal Spray (GNS) in Healthy Volunteers (NCT02563951) | Maxinase Life Sciences Ltd. | 2015-09-01 |
| A Comparative Study of Azithromycin and S-P as Prophylaxis in Pregnant HIV+ Patients (NCT02527005) | University of Ibadan | 2015-09-01 |
| Bioavailability of Belumosudil (KD025) in Healthy Male Subjects (NCT02557139) | Kadmon Corporation, LLC | 2015-09-01 |
| Sorafenib Administered Using a High-dose, Pulsatile Regimen: a Phase I Exposure Escalation Study (NCT02636426) | Amsterdam UMC, location VUmc | 2015-09-01 |
| Immunotherapy Using Pluripotent Killer-Programmed Cell Death 1 (PIK-PD-1) Cells for the Treatment of Advanced Hepatocellular Carcinoma (NCT02632006) | Second Military Medical University | 2015-09-01 |
| To Evaluate the Effect of Food on Pharmacokinetics(PK), Phase I Clinical Study of LCB01-0371 (NCT02538003) | LigaChem Biosciences, Inc. | 2015-09-01 |
| A Trial to Investigate the Efficacy, Pharmacokinetics, Safety and Tolerability of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 2 Diabetes Mellitus (NCT02562326) | Adocia | 2015-09-01 |
| Safety Study of MGD009 in B7-H3-expressing Tumors (NCT02628535) | MacroGenics | 2015-09-01 |
| CD19-targeting CAR T Cells for B Cell Lymphoma (NCT02547948) | Fuda Cancer Hospital, Guangzhou | 2015-09-01 |
| Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Venous Leg Ulcers (NCT02652572) | Xequel Bio, Inc. | 2015-09-01 |
| Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma (NCT02638857) | Second Military Medical University | 2015-09-01 |
| CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Granulocytic Sarcoma (NCT02484391) | Wake Forest University Health Sciences | 2015-09-01 |
| Study of Crenolanib Combined With Chemotherapy in FLT3-mutated Acute Myeloid Leukemia Patients (NCT02400281) | Arog Pharmaceuticals, Inc. | 2015-09-01 |
| Ficlatuzumab, Cisplatin and IMRT in Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT02277184) | Julie E. Bauman, MD, MPH | 2015-09-01 |
| Phase I Low Dose WART in Combination With Weekly Paclitaxel for Platinum Resistant Ovarian Cancer (NCT02545010) | National University Hospital, Singapore | 2015-09-01 |
| A Study to Assess the Pharmacokinetic Profile, the Safety, and the Tolerability of ME1100 Inhalation Solution in Patients With Mechanically Ventilated Bacterial Pneumonia (NCT02459158) | Meiji Seika Pharma Co., Ltd. | 2015-09-01 |
| Early In-bed Cycling in Critically Ill Children (NCT02358577) | McMaster University | 2015-09-01 |
| A Study of the Effects of Hepatic Impairment on the Pharmacokinetics and Tolerability of Eliglustat Tartrate (NCT02536911) | Genzyme, a Sanofi Company | 2015-09-01 |
| Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine at Three Different Molecular Weights in Treatment-Seeking Subjects With Opioid Use Disorder (NCT02559973) | Indivior Inc. | 2015-09-01 |
| Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin (Part 2) (NCT02656212) | Veterans Medical Research Foundation | 2015-09-01 |
| Immunotherapy Using Precision T Cells Specific to Personalized Neo-antigen for the Treatment of Advanced Malignant Tumor of Biliary Tract (NCT02632019) | Second Military Medical University | 2015-09-01 |
| Hyperpolarized Xenon-129 Magnetic Resonance Imaging and Spectroscopy of Brown Fat: Healthy Adult Volunteer Pilot Study (NCT02220426) | University of North Carolina, Chapel Hill | 2015-09-01 |
| Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular Dystrophy (NCT03067831) | Stem Cells Arabia | 2015-09-01 |
| Tolerability and Pharmacokinetics(PK)/Pharmacodynamics(PD) Study of GW003 in Healthy Subjects (NCT02643901) | Jiangsu T-Mab Biopharma Co.,Ltd | 2015-09-01 |
| Study Evaluating the Safety and Efficacy of Astarabine in Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia (NCT02544438) | BioSight Ltd. | 2015-09-01 |
| Chimeric Antigen Receptor-Modified T Cells for Breast Cancer (NCT02547961) | Fuda Cancer Hospital, Guangzhou | 2015-09-01 |
| HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA (NCT02379520) | Baylor College of Medicine | 2015-09-01 |
| Efficacy in Ablative Fractional Laser Assisted Photodynamic Therapy According to Ablative Depth for Actinic Keratosis (NCT03325803) | Dong-A University | 2015-09-01 |
| Radical Surgery Followed by Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen for the Treatment of Hepatocellular Carcinoma (NCT02632188) | Second Military Medical University | 2015-09-01 |
| Cycloserine in the Treatment of Sleep Apnea (NCT02735694) | University of Manitoba | 2015-09-01 |
| A Study to Assess the Pharmacodynamic Effect of Single Doses of AZD9977 in Healthy Male Subjects (NCT02532998) | AstraZeneca | 2015-09-01 |
| The Role of Endothelin-1 in Sickle Cell Disease (NCT02712346) | Augusta University | 2015-09-01 |
| Skeletal Muscle Dysfunction in Rheumatoid Arthritis (RA) (NCT02535832) | Ohio State University | 2015-09-01 |
| Safety and Pharmacokinetics of Multiple Doses of BI 655064 in Healthy Chinese Male Volunteers (NCT02331277) | Boehringer Ingelheim | 2015-09-01 |
| Comparing Semaglutide Administered Subcutaneously Once Daily to Semaglutide Administered Subcutaneously Once Weekly (NCT02557620) | Novo Nordisk A/S | 2015-09-01 |
| Filanesib (ARRY-520) in Combination With Pomalidomide and Dexamethasone for Relapsed/Refractory (R/R) Multiple Myeloma (MM) Patients (NCT02384083) | PETHEMA Foundation | 2015-09-01 |
| Clinical Interest of the Temporary Urethral Stent Allium " Bulbar Urethral Stent " in the Treatment of Detrusor Sphincter Dyssynergia (NCT02323243) | Hospices Civils de Lyon | 2015-09-01 |
| Study to Compare the Pharmacokinetics, Safety, and Tolerability Following Administration of Palovarotene in Healthy Japanese and Non-Asian Subjects (NCT04829786) | Clementia Pharmaceuticals Inc. | 2015-09-01 |
| Trial Evaluating Carbon Ion Radiotherapy With Concurrent Chemotherapy for Locally Recurrent Nasopharyngeal Carcinoma (NCT02801487) | Shanghai Proton and Heavy Ion Center | 2015-09-01 |
| A Study of VentriGel in Post-MI Patients (NCT02305602) | Ventrix, Inc. | 2015-09-01 |
| Dose-escalation Safety and Immunogenicity Study to Compare MTBVAC to BCG in Newborns With a Safety Arm in Adults (NCT02729571) | Biofabri, S.L | 2015-09-01 |
| Safety Study of BLZ-100 in Adult Subjects With Sarcoma Undergoing Surgery (NCT02464332) | Blaze Bioscience Inc. | 2015-09-01 |
| Ascending Dose Study of CT1812 in Healthy Volunteers (NCT02570997) | Cognition Therapeutics | 2015-09-01 |
| Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Diabetic Foot Ulcers (NCT02652754) | Xequel Bio, Inc. | 2015-09-01 |
| A Study of [¹⁴C]-LY3202626 in Healthy Male Participants (NCT02555449) | Eli Lilly and Company | 2015-09-01 |
| Injectable Collagen Scaffold™ Combined With HUC-MSCs for the Improvement of Erectile Function in Men With Diabetes (NCT02745808) | Chinese Academy of Sciences | 2015-09-01 |
| Phase I Study of BYL719 in Combination With Cisplatin and Radiotherapy in Patients With Squamous Cell Head and Neck Cancer (NCT02537223) | University Health Network, Toronto | 2015-09-01 |
| Metformin and Congenital Nephrogenic Diabetes Insipidus (NCT02460354) | Emory University | 2015-09-01 |
| Demonstrate Bioequivalence of Two 12.5 mg Empagliflozin/500 mg Metformin Fixed Dose Combination Tablets With Free Combination of Empagliflozin 25 mg and Metformin 1000 mg in Healthy Male and Female Volunteers Under Fed Conditions (NCT02577315) | Boehringer Ingelheim | 2015-09-01 |
| Caudal Block vs Local Wound Infiltration for Hernia Repair in Children (NCT02620566) | University Clinic for Anesthesia Reanimation and Intensive Care Mother Theresa | 2015-09-01 |
| Safety and Efficacy of Allogenic Adoptive Immune Therapy for Advanced AIDS Patients (NCT02651376) | Beijing 302 Hospital | 2015-09-01 |
| Study Comparing Adapalene/BP Gel to EPIDUO® FORTE and Both to a Placebo Control in Treatment of Acne Vulgaris (NCT02709902) | Sun Pharmaceutical Industries, Inc. | 2015-09-01 |
| Oral Bioavailability of Solid Formulation of GLPG1837 With and Without Food (NCT02562859) | Lakefront Biotherapeutics NV | 2015-09-01 |
| Study of a Novel BET Inhibitor FT-1101 in Patients With Relapsed or Refractory Hematologic Malignancies (NCT02543879) | Forma Therapeutics, Inc. | 2015-09-01 |
| Treatment With AZD4547 for Recurrent Malignant Glioma Expressing FGFR-TACC Gene Fusion" (NCT02824133) | Assistance Publique - Hôpitaux de Paris | 2015-09-01 |
| Ph 1 Study of VS-4718, a FAK Inhibitor, in Combination With Nab-paclitaxel and Gemcitabine in Advanced Cancer Subjects (NCT02651727) | Verastem, Inc. | 2015-09-01 |
| Phase 1 PK, Bioavailability, Safety Study of Clonidine MBT w Catapres in Healthy Volunteers (NCT02548806) | Valerio Therapeutics | 2015-09-01 |
| Telerehabilitation in the Home Versus Therapy In-Clinic for Patients With Stroke (NCT02360488) | University of California, Irvine | 2015-09-01 |
| Safety Study of Gene-modified Autologous Fibroblasts in Recessive Dystrophic Epidermolysis Bullosa (NCT02493816) | King's College London | 2015-09-01 |
| CAR-T Cell Immunotherapy for EphA2 Positive Malignant Glioma Patients (NCT02575261) | Fuda Cancer Hospital, Guangzhou | 2015-09-01 |
| Phase I Study of Olaparib Combined With Cisplatin-based Chemoradiotherapy to Treat Locally Advanced Head and Neck Cancer (NCT02308072) | University College, London | 2015-09-01 |
| Nitric Oxide in Cardiopulmonary Bypass for Renal Protection in Cardiac Surgery (NCT03527381) | Nikolay Kamenshchikov | 2015-09-01 |
| Immunotherapy Using Pluripotent Killer-Human Epidermal Growth Factor Receptor-2 (PIK-HER2) Cells for the Treatment of Advanced Gastric Cancer With Liver Metastasis (NCT02632201) | Second Military Medical University | 2015-09-01 |
| Study of the Combination of CM082 With Everolimus in Patients With mRCC (NCT02577458) | AnewPharma | 2015-09-01 |
| Buparlisib, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors (NCT01971489) | Roswell Park Cancer Institute | 2015-09-01 |
| A New Track Ablation Device for Liver Biopsy: A Feasibility Study (NCT02521129) | Samsung Medical Center | 2015-09-01 |
| A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate Lpathomab in Healthy Volunteers (NCT02341508) | Lpath, Inc. | 2015-09-01 |
| An Ascending Multiple Dose Study of CD101 IV in Healthy Subjects (NCT02551549) | Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2015-09-01 |
| A Study of the Effects of Renal Impairment on the Pharmacokinetics and Tolerability of Eliglustat Tartrate (NCT02536937) | Sanofi | 2015-09-01 |
| Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine (NCT02453048) | Institut National de la Santé Et de la Recherche Médicale, France | 2015-09-01 |
| Dose Escalation Study of ADXS31-164 in Subjects With HER2 Expressing Solid Tumors (NCT02386501) | Advaxis, Inc. | 2015-09-01 |
| A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Isatuximab in Patients With Multiple Myeloma (NCT02514668) | Sanofi | 2015-09-01 |
| Evaluating the Safety and Protective Efficacy of a Single Dose of a Trivalent Live Attenuated Dengue Vaccine to Protect Against Infection With DENV-2 (NCT02433652) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-09-01 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK001 (NCT02563938) | Allakos Inc. | 2015-09-01 |
| A Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Rhinoconjuncitivis Sensitized to Olea Europaea (NCT02849210) | Roxall Medicina España S.A | 2015-09-01 |
| Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of REMD-477 in Subjects With Type 2 Diabetes Mellitus (NCT02455011) | REMD Biotherapeutics, Inc. | 2015-09-01 |
| Comparison of Efficacy Of Probiotic Toothpaste and Chlorhexidine Mouthwash To Reduce S.Mutans (NCT03004196) | Peoples University, Bhanpur, Bhopal | 2015-09-01 |
| 28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension (NCT02531152) | Sanofi | 2015-09-01 |
| Immunotherapy Using Autologous T Cell-Engineered With CD19-specific Chimeric Antigen Receptor for the Treatment of Recurrent /Refractory B Cell Leukemia (NCT02644655) | Second Military Medical University | 2015-09-01 |
| CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients (NCT04406610) | Fuda Cancer Hospital, Guangzhou | 2015-09-01 |